InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by FAMBROUGH DOUGLAS, Chairman & CEO. Insider active across 1 companies, notably Dicerna Pharmaceuticals Inc. Cumulatively, 8 reports have been published. Total volume traded: €188k. The latest transaction was filed on 28 December 2021 — Disposition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€8m231,431 shares@ €33.759897.7% of flow
Common Stock
SEC:0001399529-21-000198·
€8m231,431 shares@ €33.759848.9% of flow
Common Stock
SEC:0001399529-21-000198:0·
13,750 shares
Common Stock
SEC:0001399529-21-000174·
13,750 shares
Common Stock
SEC:0001399529-21-000174:0·
€88,54833,670 shares@ €2.62991.1% of flow
Common Stock
SEC:0001399529-21-000162·
€88,54833,670 shares@ €2.62990.6% of flow
Common Stock
SEC:0001399529-21-000162:0·
€94,2395,000 shares@ €18.84791.2% of flow
Common Stock
SEC:0001399529-21-000146·
Ideal exit: 7 May 2022 (T+270)
€94,2395,000 shares@ €18.84790.6% of flow
Common Stock
SEC:0001399529-21-000146:0·
Ideal exit: 7 May 2022 (T+270)
8 of 8 declarations
About FAMBROUGH DOUGLAS
Douglas Fambrough is President and CEO of Dicerna Pharmaceuticals Inc. He leads the company with a focus on innovation and the development of new therapies. His leadership is pivotal to Dicerna's mission.
